Our expression of regret that Oralcer had been licensed for marketing could have been taken to imply that its safety and efficacy had been reviewed by the Committee on Safety of Medicines. The Committee did not in fact do so: the makers of Oralcer were given a licence of right.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.